chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day after the vaccine I woke with a sore arm.  Similar to a tetnus shot. By afternoon I was nauseated, I took Pepto Bismo before bed. I woke up in the night with diahrea and severe vomiting, the vomiting was so severe that my stomach muscles were sore for three days after the episode.    Sorry about the spelling errors.
Information has been received from a 51 year old female nurse with a penicillin allergy and no other pertinent medical history who, "4 years ago", in approximately August 2002, was vaccinated with a dose of MUMPSVAX. There was no concomitant medication. Subsequently when she received the vaccine she experienced a low grade fever and had mild flu-like symptoms. The patient had a titer in the "past few weeks", in November 2006 which was negative. Unspecified medical attention was sought. There was no product quality complaint involved. No additional information was provided. Additional information has been requested.
Received a 2nd dose of 0.25mL instead of 0.5mL; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Received a 2nd dose of 0.25mL instead of 0.5mL) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939904 and 039D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 ml. On 05-Nov-2021, the patient experienced ACCIDENTAL UNDERDOSE (Received a 2nd dose of 0.25mL instead of 0.5mL). On 05-Nov-2021, ACCIDENTAL UNDERDOSE (Received a 2nd dose of 0.25mL instead of 0.5mL) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2021: Significant follow up(batch number, patient's age and race information have been updated)
Vaccine was properly stored but it was expired; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer stage IV (Spread to sternum and lung) since 2019 and Penicillin allergy.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 28-Oct-2021, EXPIRED PRODUCT ADMINISTERED had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment information was reported.
Patient started with blanchable rash about 36 hours after vaccine was given.  After observation rash progressed to erythema multiforme minor (symmetrical target shaped macules that are blanchable).  No evidence of erythema mutiforme major.  No anaphylaxis
This spontaneous report was received from a pharmacist referring to 35 year old patient of unknown gender. The patient's concurrent conditions and medical history were not provided. On 28-FEB-2014 the patient was vaccinated with an expired dose of MMR II lot # 0425AE expiration date 27-FEB-2014 (route and dose were not provided). There was no concomitant medication described. It was unknown if the patient sought medical attention. No adverse effects were reported. No product quality complain was involved. Additional information has been requested.
A report has been received from a Health Professional concerning an adult, female patient. On 12-Sep-2013, the patient had received FLUMIST QUADRIVALENT (intranasal). The patient experienced massive headache which started on 12-Sep-2013. The outcome of the event of massive headache was unknown. The report was considered to be non-serious by reporter.
pt recv vax 15APR98 & same day pt exp dizziness & jitteriness;6MAY98 pt was vaccinated w/2nd dose of vax & exp some jitteriness & devel diarrhea;the reporting MD decided not to give final dose;7MAY98 pt recovered from diarrhea & jitteriness
Presents for worsening SOB, cough, fever, weakness, COVID + PTA. Admit for COVID pneumonia w/acute hypoxemic resp failure. Tx: convalescent plasma, dexamethasone, warfarin, remdesivir, O2. DC home w/HH
redness, soreness, itching, swelling @ inj site;size of fifty cent piece;verbal report only;cool pack to be appllied to site;
pt recvd vax & immed p/vax devel a localized rxn & syncope which cleared;pt was kept in MD's office for about an hr;felt lethargic afterwards;4 days later had noc sweats & GI distress;seen by ER MD;also reported some papular rashes;dysuria
This patient had a fever to 104 10 days after vaccination, 2 seizures (lasting 10 minutes each). Two ER visits, 2 doctor follow up visits. One week to recover.
I had 24 hours later, headache, fever, chills for 24 hrs. I was fine. The rashes started on 31Oct2021, I thought it was bug bites and it was itchy. I woke up and it was fine. 1Nov2021 and the rash turned into hives. I called the doctor as it progressed everywhere and even on my scalp - for a week. Got antihistamine and steroid and 70per cent better and got more antihistamine, rash the has changed and now if I touch my skin its red, inflamed and itchy.
Migraine; Pain behind eyes; Pain all over; Horrible Headache/Pounding Headache; This spontaneous case was reported by a patient and describes the occurrence of MIGRAINE (Migraine), EYE PAIN (Pain behind eyes), PAIN (Pain all over) and HEADACHE (Horrible Headache/Pounding Headache) in a 59-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 021H22A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: J&J COVID-19 Vaccine (Primary series) on 06-Mar-2021. Past adverse reactions to the above products included No adverse event with J&J COVID-19 Vaccine. Concurrent medical conditions included Migraine (and patient usually takes Motrin as needed for Migraine) and Headache (Patient also had been taking Aspirin on & off for headache). Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for Headache, NAPROXEN (MOTRIN [NAPROXEN]) for Migraine.    On 16-Nov-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-Nov-2022, the patient experienced MIGRAINE (Migraine), EYE PAIN (Pain behind eyes), PAIN (Pain all over) and HEADACHE (Horrible Headache/Pounding Headache). At the time of the report, MIGRAINE (Migraine), EYE PAIN (Pain behind eyes), PAIN (Pain all over) and HEADACHE (Horrible Headache/Pounding Headache) outcome was unknown.            It was reported that patient had first monovalent Booster of Moderna COVID-19 Vaccine on 22-Oct-2021. Patient had second monovalent Booster of Moderna COVID-19 Vaccine on 02-APR-2022. Patient did not have any side effects with the previous Moderna COVID-19 boosters. No treatment information was provided.
Fever, fatigue, sore throat, myalgia, headache, and hives. Started day after immunization and continues at day 7.
No rash, shaking, chills, insomnia 4 days.  Pt received MMR/Polio vaccine Monday 02/23.  Pt developed intermittent fevers, on Motrin and Tylenol.  Monday 03/01 (8 days later), thursday 03/04: 104.9 as high as 105.7 rectally.  At which pt was taken to ER.  Nothing was found to be wrong.  Exam normal, U/A (-), blood work normal.  By Friday 03/05 pt was afebrile.
Patient experienced tingling and burning in both arms and hands on 11/24/2020.  Patient weak in both arms and hands,  crepitus in both arms. Went to ER for shoulder, thought popped out of socket in the following days. Pain level 9/10.  Tear on rotator cuff. Patient feels that this was in relation to his vaccination. Patient pushed shoulder back into socket, visited ER.  Surgeon referred Patient to  Primary doctor to run blood work.  Quivering still ongoing in both arms and hands;  'hard to make a fist'.  Ongoing symptoms; muscles tight on left and right side; 'Feels like someone pressing right down on the bone' in both arms. Waiting for lab results from PCP.
Patient states she is having pain from shoulder to elbow, across her back an inch below her waist, and down both thighs to her knees - this was reported on 11/7/15 - vaccine administered on 10/15/15.
I received the COVID-19 one-dose vaccine. Day one post vaccination, I felt feverish but that passed after sleeping for 20 hours. Negative arm soreness. Over the next 2 weeks, a very specific rash developed, deepened, and faded: When I removed my athletic socks nearly 1 day post-vaccination, there appeared to be a red sock on my skin (red marks exactly matching the texture of the sock where it touched my skin). I did not need to wear socks after I removed them. The red marks went from being faint pink to deeply pink to burgundy before fading back and going away - this took approximately 2 weeks. The socks were previously washed in the same laundry load as other socks which I wore before and after vaccination (100% cotton socks, washed in laundry detergent with no dye or scent, main named brand), and the issue was not seen pre- or post-vaccination. The rash was not itchy or painful, merely disconcerting as I did not know if it would become itchy or painful or worsen beyond what became its worse point. Overall, no adverse effects - I did feel feverish 1 day post vaccination and slept a LOT, but felt that my reaction was much better than reactions reported publicly by others. The rash was concerning, but ultimately not injurious. If a star rating is allowed without redaction, I would give the vaccine 4.5 out of 5 stars - nearly perfect. But that rash kind of weirded me out, I couldn't find anything online about it. Patient factors: Tomato allergy, no other allergy discovered. Socks from their same original package laundered the same way, problem was not produced prior or reproduced after as of the report date. I do not require follow-up or confirmation personally (feel free to consider this 'customer contact complete' but will be happy to answer any questions. Unfortunately I did not save the photos I had sent to my personal contacts.
A day after vaccines were administered, pt presented with slight swelling and rash only on left leg.
UTI like symptoms, frequent urination, burning on urination beginning 11 days after initial dose, continuing sporadically to present time, 9 months later. Treated twice with Macrobid, once with Augmentin. Also treated in March 09 for yeast infection. Persistant headache, vertigo, blurry vision incapacitating, beginning two months after second dose and continuing for another two months. During these months also experienced anxiety/panic attacks/depression, diarrhea, vomiting. Blood and urine tests all normal. MRI and CT scan revealed nothing. Pap test revealed abnormal cells at the moderate level. All symptoms were beginning to improve when the last dose was given because no one had yet connected the dots....Then exactly two months after the last dose all symptoms returned in full. Headache, blurry vision, vertigo, frequent and burning urination. Patient is now 3 months from the last dose of gardasil and is now starting to feel less bad!
Mom came into HP with pt today and said he has a reaction to one of his shots. (L) arm where VZV was given was swollen, red, hard and looked like it had been scratched. Mom said it started on the 3-28-17 with just swelling, but it has gotten worse. She said she has given him TYLENOL and put cool packs to it 2x yesterday. Inst mom to give BENADRYL daily and apply cool packs 4-5x daily. Call mom if no better. Also cont. TYLENOL every 4-6 Hrs.
Area from shoulder to elbow (L) was swollen and initially had been beet red. On 4/10/02, spoke to father and she is fine now. Treated with Benadryl, ice (cool pads 30 minutes qid) and ibuprofen q6h prn.
Pfizer bivalent vaccine was given instead of the first dose of the pfizer monovalent vaccine for 5-11 year old. No signs/symptoms at this time of adverse reaction.
Pt had some sort of as still unknown medical episode that caused him to crash his car (hit guardrail and flipped car twice, had to be cut out of car). He fractured his T1 and had subdural hematomas (now classified as a TBI). He had extensive workups during hospital stay that failed to ID a cause. He was released from hospital on a Holter monitor then ended up having episode of SVT and VTach, which prompted a procedure and he now has an implanted loop recorder in his chest and has to take a medication. He did not have this before getting the vaccine, which he did not want to get but was required to by the hospital where he works. He was off work for almost 6 months. He still has mild memory problems related to the TBI and will probably be on medication for his heart rate for life. He did a trial run off the medication and had the heart dysrhythmia again. He has retrograde amnesia related to the accident.
This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non- pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534,), via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 32-years-old) at 09:45 as a single dose for COVID-19 immunisation. Medical history included allergies (unspecified) and herpes simplex virus. The patient had a history of allergy to erythromycin. Concomitant medications included valacyclovir (MANUFACTURER UNKNOWN), ethinylestradiol; norgestimate (SPRINTEC), mometasone furoate (FLONASE), cetirizine hydrochloride (ZYRTEC) for unknown indication from an unspecified date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6198), via an unspecified route of administration in the left arm on 02Mar2021 at 09:30 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had not been tested for COVID-19 since having the vaccine. On 23Mar201 at 12:00, the patient had experienced sore arm, fever of 100F, fatigue, pounding headache, tiredness and cold during the day. On the same day, the patient also experienced chills and reported that she could not get warm under 5 blankets for the entire night. The patient did not receive any treatment for the reported events. Adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events arm soreness, fever 100F, chills, tiredness/fatigue, headache and could not get warm under 5 blankets for the entire night, cold during the day was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Received Shingrix vaccines in 2019, got an outbreak 2 weeks ago/suspected vaccination failure; Got an outbreak anyway; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. In October 2022, more than 2 years after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.   Additional Information: GSK Receipt Date: 21-OCT-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient received the Shingrix vaccines in 2019 and paid full price for them at great expense. The patient states that, two weeks ago from reporting he/she got an outbreak of shingles anyway. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
PATIENT EXPERIENCED A "HOT FLASH' AND TIGHT THROAT AT ITHE 15 MIN MARK, COLD AND CLAMMY FOREHEAD,  121/79  89, 100 %  GIVEN COLD WATER TO SIP, REPORTS NO DIFFICULTY SWALLOWING AND IMPROVED TIGHTNESS WITH SIPS.  0935    SIDE EFFECTS RESOLVED DISCHARGED AT 945 TOLD PO'S NOT THROAT TIGHTNESS.  PATIENT EDUCATED TO REPORT SIDE EFFECT TO VACINATOR AT SECOND DOSE APPOINTMENT PRIOR TO ADMINISTRATION.  PATIENT VERBALIZED UNDERSTANDING OF PATIENT CARE PLAN.
No additional AEs; HBP reported that VARIVAX was administered to a patient on 01/05/2023 after a temperature excursion. No further information was provided. Providers information was obtained and consent to contact was provided. No additional AEs/no PQCs.          ?; This spontaneous report was received from office manager and refers to a 23-month-old patient of an unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not reported.  On 05-JAN-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX), lot # W017551, expiration date 01-JUN-2024 (dose, route of administration and anatomical location were not provided) for prophylaxis. Administered dose of suspect vaccine experienced temperature excursion from 6 degrees Fahrenheit (F) up to 14F for 10 minutes and from 14 F up to 46 F for 40 minutes (Product storage error). There was no previous temperature excursion. No additional adverse event.
felt worse than when I actually had Covid in Feb 2021; Sore everywhere; muscle aches; headache; congestion; chills; fever over 102 degrees; This is a spontaneous report from contactable Consumer or other non-HCP (patient). A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: not reported) via an unspecified route of administration, administered in right arm on 25Mar2021 15:15 (at the age of 46-yar-old) as dose 1, single for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Medical history included high blood pressure, diabetes both are ongoing from an unknown date and Covid on an unspecified date in Feb 2021 and unknown if ongoing. Patient had no allergies to medications, food, or other products. Concomitant medications within 2 weeks of vaccination included Ambien via an unspecified route of administration from an unknown date for an unspecified indication unknown if ongoing. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 26Mar2021 06:00, Beginning 15 hours after injection, the patient experienced felt worse than when I actually had Covid in Feb 2021, Sore everywhere, muscle aches, headache, congestion, chills, and fever over 102 degrees. On 26Mar2021, the patient underwent lab tests and procedures which included Body temperature: over 102 degrees. Patient did not receive any treatment for the events. Therapeutic measures were taken as a result of the events which included Tylenol and aspirin did not help. Events were non-serious. The outcome of the event was recovering (Symptoms began improving about 40 hours after injection).  No follow-up attempts are needed. No further information is expected.
Unauthorized booster dose administered to a minor, 14 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized booster dose administered to a minor, 14 year old) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027h21b) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter once. On 13-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized booster dose administered to a minor, 14 year old). On 13-Jan-2022, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized booster dose administered to a minor, 14 year old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Case previously recorded as MA2009-6261. Initial case report received from a health care professional on 25 NOV 2009. Twenty children younger than 04 years of age received FLUVIRIN intramuscular inadvertent administration on an unknown date. No adverse events reported. Medical history: Not reported. Reference no. NA09-008851.
client was given booster 10 days beforet he due date. this was due to nurse understanding in the manual that the  booster should be given 5 months after 1 st dose in the series.
Mom called triage RN on 4/7/00 to report possible vaccine reaction or infection from vaccine given on 4/5/00 (DTAP in Right lateral thigh). Mom states "no alcholol pad was used before the injection". Pt seen by PCP 4/7/00 and given antibiotics.
redness, itchy, rash, swollen, 2-3 inchesa from injection site-bicept area
Pt called health department 05/27/02 to report a reaction to Td received on 12/23/02.  (See attached faxed report); 1/07/03; Pt reported that adverse reaction was completely gone in 1 week of receiving the vaccine.
This spontaneous report as received from a nurse practitioner via a company representative refers to a 9 year old male patient. No information regarding the patient's medical history and concurrent conditions was provided. In approximately August 2016 (reported as "about one month ago"), the patient was vaccinated with the first dose of GARDASIL 9 injection, (dose, route of administration, injection site, lot number and expiration date were not provided). There were no concomitant medications reported. On an unspecified date in 2016, the patient started feeling pain in his left arm. It was not specified how long after receiving the first dose of GARDASIL 9 the pain occurred. The nurse practitioner also stated that the patient was "not able to sleep because of the pain" since an unknown date in 2016. The patient sought medical attention via contacting the nurse practitioner. An unspecified treatment was given for the events. The outcome of feeling pain in the left arm and not being able to sleep because of the pain was unknown since the patient had not returned to the office until the day of this report. The relatedness between the events and suspect therapy was not provided. Additional information has been requested.
Shortly after the vaccination, came back with a hiver on his eyelid. No breathing issues. Informed to take Benadryl and follow up with primary care provider. Called back next day to report he was fine and hive was resolved.